Fundraising Fox

Escalante Bioscience

San Francisco, US · Founded 2024 · Delaware corporation

Founders & leadership

AT
Akshay TambeNamed on SEC filing
AD
April D SchleckNamed on SEC filing
CH
Ching-Yun HsuNamed on SEC filing
NR
Nicholas R BoydNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$6.7M disclosed across 1 round · 2024

$6.7MraisedMay 2024 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Akshay TambeDirector
  • April D SchleckExecutive Officer, Director
  • Ching-Yun HsuExecutive Officer, Director
  • Nicholas R BoydDirector
Offering amount
$6.7M
Amount sold
$6.7M
First sale
May 2024
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Escalante Bioscience raised?
Escalante Bioscience has disclosed $6.7M raised across 1 round.
Where is Escalante Bioscience headquartered?
Escalante Bioscience is headquartered in San Francisco, US.